Atlas Trials

Managed Access Programs for VAY736, Ianalumab

Clinical trial NCT07244289 · AVAILABLE

Trial details

NCT number
NCT07244289
Sponsor
Novartis Pharmaceuticals
Status
AVAILABLE
Study type
EXPANDED_ACCESS
Primary Immune ThrombocytopeniaSjögren's Syndrome

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.